Abstract
This prospective study on Bell’s palsy investigated the value of 3 T MRI as a diagnostic tool to evaluate pathophysiological changes (i.e. edema) of facial nerve segments and the possibility to differentiate patients with high risk for incomplete recovery from patients who recover completely within 3 days after symptoms onset. For this institutional review board approved investigation, thirty patients (14 male, 16 female, mean age 44 years) with Bell’s palsy underwent pre and postcontrast 3 T MRI of the cerebellopontine angle. T1-weighted imaging was performed (TR 20.0 ms, TE 2.46 ms, isotropic voxel size: 0.6 mm). Region-of-interest measurements were performed on the healthy and paralyzed side. To obtain normalized values, signal intensity increase percentage (SIIP) values were divided by contralateral results of the healthy side. Signal intensity measurements of examined nerve segments were compared using Wilcoxon and Mann–Whitney U tests and correlated to clinical findings categorized by the House–Brackmann score. The lesion side showed significantly higher signal intensities in the premeatal segment before and after contrast agent administration (P < 0.001). SIIP was highest in the premeatal segment compared to the geniculate ganglion (P < 0.001). Correlation analyses revealed no association between signal intensity measurements, clinical findings or early recovery rates after 3 months (P > 0.05). According to our results, early palsy-associated pathophysiological changes in the facial nerve premeatal segment might also be related to accumulation of proteins and not exclusively to edema. However, contrast agent enhancement quantification was not suitable as a diagnostic tool to distinguish different prognostic groups.
Similar content being viewed by others
References
Gilden DH (2004) Bell’s palsy. N Engl J Med 351(13):1323–1331
Peitersen E (2002) Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 549:4–30
Marson AG, Salinas R (2000) Bell’s palsy. West J Med 173(4):266–268
Berg T, Marsk E, Engstrom M, Hultcrantz M, Hadziosmanovic N, Jonsson L (2009) The effect of study design and analysis methods on recovery rates in Bell’s palsy. Laryngoscope 119(10):2046–2050
Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkaranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L (2008) Prednisolone and valaciclovir in Bell’s palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 7(11):993–1000
Sullivan FM, Swan IRC, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F (2007) Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 357(16):1598–1607
Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, Fukuda S, Furuta Y, Ohtani F, Aizawa H, Aoyagi M, Inamura H, Nakashima T, Nakata S, Murakami S, Kiguchi J, Yamano K, Takeda T, Hamada M, Yamakawa K (2007) Valacyclovir and prednisolone treatment for Bell’s palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 28(3):408–413
Grosheva M, Wittekindt C, Guntinas-Lichius O (2008) Prognostic value of electroneurography and electromyography in facial palsy. Laryngoscope 118(3):394–397
Sartoretti-Schefer S, Brandle P, Wichmann W, Valavanis A (1996) Intensity of MR contrast enhancement does not correspond to clinical and electroneurographic findings in acute inflammatory facial nerve palsy. AJNR Am J Neuroradiol 17(7):1229–1236
Yetiser S, Kazkayas M, Altinok D, Karadeniz Y (2003) Magnetic resonance imaging of the intratemporal facial nerve in idiopathic peripheral facial palsy. Clin Imaging 27(2):77–81
Kress B, Griesbeck F, Efinger K, Solbach T, Gottschalk A, Kornhuber A, Bähren W (2002) Bell’s palsy: what is the prognostic value of measurements of signal intensity increases with contrast enhancement on MRI? Neuroradiology 44(5):428–433
Kress B, Griesbeck F, Stippich C, Bahren W, Sartor K (2004) Bell palsy: quantitative analysis of MR imaging data as a method of predicting outcome. Radiology 230(2):504–509
Song MH, Kim J, Jeon JH, Cho CI, Yoo EH, Lee W-S, Lee H-K (2008) Clinical significance of quantitative analysis of facial nerve enhancement on MRI in Bell’s palsy. Acta Otolaryngol 128(11):1259–1265
Kefalidis G, Riga M, Argyropoulou P, Katotomichelakis M, Gouveris C, Prassopoulos P, Danielides V (2010) Is the width of the labyrinthine portion of the fallopian tube implicated in the pathophysiology of Bell’s palsy? A prospective clinical study using computed tomography. Laryngoscope 120(6):1203–1207
Engström M, Thuomas KA, Naeser P, Stalberg E, Jonsson L (1993) Facial nerve enhancement in Bell’s palsy demonstrated by different gadolinium-enhanced magnetic resonance imaging techniques. Arch Otolaryngol Head Neck Surg 119(2):221–225
Fisch U, Esslen E (1972) Total intratemporal exposure of the facial nerve. Pathologic findings in Bell’s palsy. Arch Otolaryngol 95(4):335–341
Schwaber MK, Larson TC, Zealear DL, Creasy J (1990) Gadolinium-enhanced magnetic resonance imaging in Bell’s palsy. Laryngoscope 100(12):1264–1269
Tien R, Dillon WP, Jackler RK (1990) Contrast-enhanced MR imaging of the facial nerve in 11 patients with Bell’s palsy. AJNR Am J Neuroradiol 11(4):735–741
Yanagihara N, Honda N, Hato N, Murakami S (2000) Edematous swelling of the facial nerve in Bell’s palsy. Acta Otolaryngol 120(5):667–671
Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, Matsuzaki Y, Nishimura H, Ishikawa H, Fukao A, Hongo S, Aoyagi M (2007) Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell’s palsy. Laryngoscope 117(1):147–156
Burmeister HP, Hause F, Baltzer PAT, Schmidt P, Volk GF, Guntinas-Lichius O, Sedlacik J, Mentzel H-J, Kaiser WA (2009) Improvement of visualization of the intermediofacial nerve in the temporal bone using 3T magnetic resonance imaging: part 1: the facial nerve. J Comput Assist Tomogr 33(5):782–788
Fu SY, Gordon T (1997) The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14(1–2):67–116
Makwana M, Raivich G (2005) Molecular mechanisms in successful peripheral regeneration. FEBS J 272(11):2628–2638
Kinoshita T, Ishii K, Okitsu T, Ogawa T, Okudera T (2001) High-intensity facial nerve lesions on T2-weighted images in chronic persistent facial nerve palsy. Neuroradiology 43(5):388–392
Seddon H (1943) Three types of nerve injury. Brain 66:237–288
Liu HM, Yang LH, Yang YJ (1995) Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol 54(4):487–496
Balkany T, Fradis M, Jafek BW, Rucker NC (1991) Intrinsic vasculature of the labyrinthine segment of the facial nerve—implications for site of lesion in Bell’s palsy. Otolaryngol Head Neck Surg 104(1):20–23
Ogawa A, Sando I (1982) Spatial occupancy of vessels and facial nerve in the facial canal. Ann Otol Rhinol Laryngol 91(11):14–19
May M (2000) Anatomy for the clinician. In: May M, Schaitkin BM (eds) The facial nerve, 2nd edn. Thieme, New York, pp 19–56
Seok JI, Lee DK, Kim KJ (2008) The usefulness of clinical findings in localising lesions in Bell’s palsy: comparison with MRI. J Neurol Neurosurg Psychiatry 79(4):418–420
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Burmeister, H.P., Baltzer, P.A.T., Volk, G.F. et al. Evaluation of the early phase of Bell’s palsy using 3 T MRI. Eur Arch Otorhinolaryngol 268, 1493–1500 (2011). https://doi.org/10.1007/s00405-011-1498-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-011-1498-x